BR vs CCEL · P/E 16, rev $6.89B vs P/E 490, $39.6M cap
Broadridge Financial Solutions Inc (BR) versus CryoCell International Inc (CCEL) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
CCEL does not have a complete income-statement cache yet.
BR currently screens at market cap $17.65B and trailing P/E 16.3. CCEL currently screens at market cap $39.6M and trailing P/E 490.0.
Not investment advice. Open the BR and CCEL stock pages for the full models.
Not investment advice.